Human immunodeficiency viral infection and differences in interstitial ventricular fibrosis and left atrial size.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
20 07 2021
Historique:
received: 03 06 2020
accepted: 18 02 2021
pubmed: 12 3 2021
medline: 7 8 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

The extent to which human immunodeficiency viral (HIV) infection is independently associated with myocardial disease in the era of combination antiretroviral therapy (cART) remains understudied. We assessed differences in cardiovascular magnetic resonance imaging (CMR) metrics among people living with HIV (PLWH) and without HIV (PWOH). Among 436 participants (aged 54.7 ± 6.0 years, 29% women) from three cohorts, we acquired CMR cines, late gadolinium enhancement (LGE), and T1 mapping. Multivariable linear regressions were used to evaluate associations between HIV serostatus and CMR metrics. Baseline characteristics were similar by HIV serostatus; 63% were PLWH of whom 88% received cART and 73% were virally suppressed. Median left ventricular ejection fraction was normal and similar by HIV serostatus (73%, PWOH vs. 72%, PLWH, P = 0.43) as were right ventricular function, biventricular volumes, and masses. LGE prevalence was similar (32%, PWOH vs. 36%, PLWH, P = 0.46) with low scar extents (4.1, PWOH vs. 4.9 g, PLWH, P = 0.51) and few ischaemic scars (3%, PWOH vs. 4%, PLWH, P = 0.70). Extracellular volume fraction (ECV) was higher among PLWH (29.2 ± 4.1% vs. 28.3 ± 3.7%, P = 0.04) as was indexed maximum left atrial (LA) volume (LAVI, 29.7 ± 10.3 vs. 27.8 ± 8.7 mL/m2, P = 0.05). After multivariate adjustment, ECV was 0.84% higher among PLWH (P = 0.05) and LAVI was 2.45 mL/m2 larger (P = 0.01). HIV seropositivity and higher ECV contributed to higher LAVI (P < 0.02). There were no associations between HIV disease severity and CMR metrics among PLWH. HIV seropositivity was independently associated with greater diffuse non-ischaemic fibrosis and larger LA volume but no other differences in CMR metrics.

Identifiants

pubmed: 33693554
pii: 6161227
doi: 10.1093/ehjci/jeab037
pmc: PMC8291675
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

888-895

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL126552
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036297
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146201
Pays : United States
Organisme : United States National Institutes of Health

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Références

Eur Heart J. 2019 Feb 7;40(6):529-538
pubmed: 30445559
JACC Heart Fail. 2019 Sep;7(9):759-767
pubmed: 31401096
Circ Cardiovasc Imaging. 2018 Dec;11(12):e007512
pubmed: 30562112
BMC Med Imaging. 2010 Jan 11;10:1
pubmed: 20064248
Circ Cardiovasc Imaging. 2019 Dec;12(12):e009535
pubmed: 31838882
Epidemiology. 1998 Mar;9(2):117-25
pubmed: 9504278
Curr HIV/AIDS Rep. 2018 Jun;15(3):233-244
pubmed: 29752699
Circ Cardiovasc Imaging. 2016 Mar;9(3):e004091
pubmed: 26951603
Circ Cardiovasc Imaging. 2016 Aug;9(8):
pubmed: 27511974
Circ Cardiovasc Imaging. 2016 Mar;9(3):e004430
pubmed: 26951605
NIDA Res Monogr. 1991;109:75-100
pubmed: 1661376
J Cardiovasc Magn Reson. 2013 Oct 14;15:92
pubmed: 24124732
Eur Heart J Cardiovasc Imaging. 2020 Apr 1;21(4):446-453
pubmed: 31504357
Int J Cardiovasc Imaging. 2019 Jan;35(1):41-48
pubmed: 30076516
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):615-621
pubmed: 29617988
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):44-54
pubmed: 31103587
J Infect Dis. 2015 Nov 15;212(10):1544-51
pubmed: 25964507
Am J Cardiol. 2016 Jan 15;117(2):214-20
pubmed: 26639041
J Am Heart Assoc. 2019 Jul 16;8(14):e012241
pubmed: 31266386
J Cardiovasc Magn Reson. 2015 Apr 18;17:29
pubmed: 25928314
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):168-176
pubmed: 30325426
Am J Epidemiol. 1987 Aug;126(2):310-8
pubmed: 3300281
J Cardiovasc Electrophysiol. 2017 Jul;28(7):796-805
pubmed: 28429529
Circulation. 2007 Apr 17;115(15):2006-14
pubmed: 17389270
J Am Coll Cardiol. 2013 Oct 1;62(14):1280-1287
pubmed: 23871886
Eur Heart J. 2012 May;33(10):1268-78
pubmed: 22279111
Radiology. 2014 Dec;273(3):703-13
pubmed: 25019562
Circulation. 2013 Aug 20;128(8):814-22
pubmed: 23817574

Auteurs

Katherine C Wu (KC)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Blalock 559, 600 North Wolfe Street, Baltimore, MD 21287, USA.

Sabina A Haberlen (SA)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Michael W Plankey (MW)

Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.

Frank J Palella (FJ)

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Damani A Piggott (DA)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Gregory D Kirk (GD)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Joseph B Margolick (JB)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Wendy S Post (WS)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Blalock 559, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH